G6052 Meprobamate HCPCS Reimbursement & Policy

HCPCS Level II code G6052 designates Meprobamate, a pharmaceutical billed as a drug supply or administration code. Nationally, medication supply codes are important for accurate pharmacy reimbursement, clinical documentation, and payer coverage determinations. Meprobamate is historically used as an anxiolytic or sedative and appears in claims where the medication itself is billed separately from professional or facility services.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what this code represents, typical sites of service, and the clinical context in which Meprobamate might be billed. The publication covers benchmark considerations and payer coverage patterns where available, notes common billing modifiers when present in the input, and highlights policy or coding updates relevant to HCPCS drug-level reporting.

This summary is intended for national audiences including coding professionals, billing managers, and policy analysts who need a clear reference for HCPCS Level II drug billing and the operational implications of reporting Meprobamate under G6052. Data not available in the input is identified where applicable.

Billing Code Overview

HCPCS Level II code G6052 represents Meprobamate, a medication typically used as an anxiolytic or sedative. The service type for this code is drug administration / pharmaceutical supply, reflecting billing for the medication itself rather than a procedure. The typical site of service is outpatient or ambulatory settings where medications are administered or dispensed, including clinics, physician offices, and outpatient infusion or medication administration centers.

Data not available in the input.

Clinical Context

A typical patient receiving medication coded as G6052 (Meprobamate) is an adult with an anxiety disorder, acute anxiety exacerbation, or severe muscle spasm for whom short-term anxiolytic therapy is indicated. The clinical workflow begins in an outpatient behavioral health clinic, primary care office, or emergency department where the clinician documents the diagnosis, reviews prior medications, assesses risk (including substance use and respiratory status), and determines that a short course of meprobamate is appropriate. The medication is dispensed from the facility pharmacy or administered on-site when an occasional in-clinic dose is required for acute symptom control. Typical encounters include medication reconciliation, counseling on risks and side effects, monitoring for sedation or respiratory depression, and scheduling follow-up for therapy adjustment or tapering. Billing for G6052 may include the technical component modifier TC when only the supply or pharmacy/technical dispensing component is billed by the facility rather than a professional dispensing service.

Coding Specifications

Modifier	Description	When to Use
`TC`	Technical component	Use when billing only the facility or pharmacy technical component for dispensing the medication or supplying the drug under institutional billing.

Taxonomy Code	Specialty	Notes
2084P0800X	Psychiatry & Neurology - Psychiatry	Psychiatrists commonly manage anxiolytic pharmacotherapy including short-term meprobamate use.
207Q00000X	Family Medicine	Primary care clinicians frequently initiate and manage short-term anxiolytic medications.
207R00000X	Internal Medicine	Internists manage anxiety disorders and may prescribe or oversee short-term sedative therapy.
363L00000X	Emergency Medicine	Emergency physicians may administer short-acting anxiolytics for acute agitation or anxiety and arrange dispensing.
3336S0200X	Pharmacy	Pharmacists handle dispensing, compounding, and technical billing responsibilities associated with medication supply.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F41.1`	Generalized anxiety disorder	Common indication for short-term anxiolytic therapy including agents like meprobamate for acute symptom control.
`F41.0`	Panic disorder [episodic paroxysmal anxiety]	Acute panic symptoms may prompt short-term pharmacologic intervention.
`F43.10`	Post-traumatic stress disorder, unspecified	Patients with severe anxiety or hyperarousal symptoms may receive short courses of anxiolytics.
`G47.00`	Insomnia, unspecified	Severe sleep disturbance related to anxiety may be treated temporarily with sedative-anxiolytic agents.
`M62.81`	Muscle weakness (generalized)	Muscle spasm or tension associated with anxiety or musculoskeletal conditions can be an indication for muscle relaxant/anxiolytic therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for follow-up visits to assess response, adverse effects, and need for continued meprobamate therapy.
`99283`	Emergency department visit for the evaluation and management of a patient, moderate severity	Used when meprobamate is administered or prescribed during an ED visit for acute anxiety or agitation.
`90833`	Psychotherapy with E/M, 30 minutes with patient present	May accompany medication management when brief psychotherapy or counseling is provided during the same visit.
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Applicable if meprobamate is administered by injection in a clinical setting as part of acute management.
`90471`	Immunization administration (Note: not directly for meprobamate)	Data not applicable — placeholder to indicate no direct immunization relation; excluded in typical workflows.

OpenPayer

Summary & Overview

HCPCS G6052: Meprobamate Medication Supply